These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. Fang Y; Xu C; Fu YX; Holers VM; Molina H J Immunol; 1998 Jun; 160(11):5273-9. PubMed ID: 9605124 [TBL] [Abstract][Full Text] [Related]
5. [Role of the complement C3 protein in the control of the specific immune response]. Villiers CL; Villiers MB; Marche PN Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739 [TBL] [Abstract][Full Text] [Related]
6. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease. Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881 [TBL] [Abstract][Full Text] [Related]
7. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists. Kulik L; Chen K; Huber BT; Holers VM Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698 [TBL] [Abstract][Full Text] [Related]
8. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement. Imai M; Ohta R; Varela JC; Song H; Tomlinson S Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. Gustavsson S; Kinoshita T; Heyman B J Immunol; 1995 Jun; 154(12):6524-8. PubMed ID: 7759885 [TBL] [Abstract][Full Text] [Related]
11. Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice. Whipple EC; Shanahan RS; Ditto AH; Taylor RP; Lindorfer MA J Immunol; 2004 Aug; 173(4):2297-306. PubMed ID: 15294942 [TBL] [Abstract][Full Text] [Related]
12. Immunization of chickens with an agonistic monoclonal anti-chicken CD40 antibody-hapten complex: rapid and robust IgG response induced by a single subcutaneous injection. Chen CH; Abi-Ghanem D; Waghela SD; Chou WK; Farnell MB; Mwangi W; Berghman LR J Immunol Methods; 2012 Apr; 378(1-2):116-20. PubMed ID: 22366632 [TBL] [Abstract][Full Text] [Related]
13. Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21). Prodinger WM; Schwendinger MG; Schoch J; Köchle M; Larcher C; Dierich MP J Immunol; 1998 Nov; 161(9):4604-10. PubMed ID: 9794388 [TBL] [Abstract][Full Text] [Related]
14. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens. Sloat BR; Shaker DS; Le UM; Cui Z FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342 [TBL] [Abstract][Full Text] [Related]
15. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli. Sloat BR; Cui Z Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937 [TBL] [Abstract][Full Text] [Related]
16. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. Finkelman FD; Lees A; Birnbaum R; Gause WC; Morris SC J Immunol; 1996 Aug; 157(4):1406-14. PubMed ID: 8759720 [TBL] [Abstract][Full Text] [Related]
17. Novel roles for murine complement receptors type 1 and 2 I. Regulation of B cell survival and proliferation by CR1/2. Molnár E; Erdei A; Prechl J Immunol Lett; 2008 Mar; 116(2):156-62. PubMed ID: 18243341 [TBL] [Abstract][Full Text] [Related]
18. Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109. Gu M; Hine PM; James Jackson W; Giri L; Nabors GS Vaccine; 2007 Jan; 25(3):526-34. PubMed ID: 16973247 [TBL] [Abstract][Full Text] [Related]
19. C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes. Van den Berg CW; Hazenberg MA; Hofhuis FM; Van Rooyen SM; Van Dijk H Immunology; 1991 Jul; 73(3):264-70. PubMed ID: 1879875 [TBL] [Abstract][Full Text] [Related]
20. [Immune response induced by combinant immunization of different HBsAg vaccines in mice]. Wu T; Chen M; Ou SH; Yan YQ; Wu XL; Zhang J; Xia NS Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):568-70. PubMed ID: 16948896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]